France halts Gaza evacuations over antisemitism row involving Palestinian student
The move comes after it was revealed that Nour Atallah, a 25-year-old woman from Gaza, had posted antisemitic content on social media before being accepted into a prestigious French university.
French foreign minister Jean-Noël Barrot announced the decision in Paris on Thursday.
'She must leave the country. She does not have a place in France,' Mr Barrot said in an interview with radio station France Info, without naming the student.
He did not specify whether the student would be sent back to Gaza.
He added that no new visas will be issued, and no new admissions from Gaza will take place until an investigation is conducted.
The French and Israeli vetting of her before she arrived in France did not reveal the 'antisemitic and unacceptable' posts, Mr Barrot said.
The temporary suspension will also see a review of all Gaza evacuees who have arrived in France so far. The scandal has triggered strong condemnation across France's political spectrum.
Ms Atallah, who had been awarded a scholarship to study at Sciences Po Lille, faces expulsion from France after her university withdrew her accreditation.
Her social media posts surfaced recently, containing antisemitic rhetoric and praise of Adolf Hitler.
French authorities say a criminal investigation has been opened on the grounds of 'justifying terrorism and crimes against humanity'.
French interior minister Bruno Retailleau wrote on X that he has requested legal action to be taken.
' Hamas propagandists have no place in our country,' he added.
Since October, France has evacuated more than 500 people from Gaza, including children, journalists, and artists, as part of its ongoing humanitarian efforts. The incident has placed renewed scrutiny on the vetting procedures coordinated with Israeli authorities.
A statement from Sciences Po Lille said the content of the student's post was 'in direct contradiction' with its values.
'(Sciences Po Lille) fights against all forms of racism, antisemitism, and discrimination, as well as against any type of call to hatred, against any population whatsoever,' the university said on X on Wednesday.
The French government has not said when evacuations might resume, promising a thorough review and strengthened protocols before any further admissions from Gaza will be considered.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
28 minutes ago
- The Independent
First migrants detained under ‘one in, one out' deal as PM vows to secure border
The first small boat migrants have been detained under the UK's new 'one in, one out' deal with Emmanuel Macron and could be sent back to France within weeks. Home Secretary Yvette Cooper said the Government was prepared to defend itself against legal challenges if migrants seek to avoid being sent back across the English Channel. The migrants detained were among those who risked the Channel crossing on Wednesday, the day the pilot scheme began operating. Prime Minister Sir Keir Starmer said: 'We have detained the first illegal migrants under our new deal before returning them to France. No gimmicks, just results. 'If you break the law to enter this country, you will face being sent back. When I say I will stop at nothing to secure our borders, I mean it.' The pilot scheme was set up as part of a deal announced by the Prime Minister and French president Mr Macron during his state visit to the UK in July. UK officials aim to make referrals for returns to France within three days of a migrant's arrival by small boat while French authorities will respond within 14 days. This is in exchange for an approved asylum seeker in France to be brought to the UK under a safe route. No figures have been confirmed for how many migrants will be sent back, although reports from France have suggested it could be around 50 a week, a small fraction of the numbers making the crossing in small boats. The Home Secretary said: 'The pilot has now begun, so the first migrants who have arrived on the small boats are now in detention. We will then swiftly make the referrals to France and that process will now start to be able to return people to France. 'It's the beginning of the pilot and it will build as well over time, but we're also clear that France is a safe country, so we will robustly defend against any legal challenge that people try. 'We do expect for people to start being returned in a matter of weeks.' The Home Office is expected to launch a campaign in the coming days to make migrants in northern France and elsewhere aware of the new treaty. Ms Cooper added: 'Criminal gangs have spent seven years embedding themselves along our border and it will take time to unravel them, but these detentions are an important step towards undermining their business model and unravelling the false promises they make.' The Home Secretary has acknowledged the accord is not a 'silver bullet' to stop small boat crossings, which are running at record levels so far in 2025. But the Government hopes it will be a turning point as migrants will be sent back across the Channel for the first time. The process for asylum seekers to come to the UK under the 'one in, one out' pilot scheme has also been launched, with adults and families in France able to express an interest in coming to the UK through an online platform set up by the Home Office. They will have to meet suitability criteria, a standard visa application process and security checks. If accepted, they would be given three months in the UK to claim asylum or apply for a visa, and would be subject to the same rules for all asylum seekers not allowed to work, study or have access to benefits. Shadow home secretary Chris Philp said just a 'token handful' of migrants had been detained and suggested the pilot scheme would fail. He said: 'Keir Starmer's promise last year to 'smash the gangs' has turned out to be nothing more than a gimmick that didn't work, and this is just the same. 'They are detaining a token handful of arrivals and in return we accept unvetted migrants from France. The whole thing is riddled with loopholes, opt-outs and legal escape routes that will make removals near-impossible.'
The Independent
28 minutes ago
- The Independent
‘Tattletale' Kemi Badenoch got a fellow pupil expelled after catching him cheating in exam
Kemi Badenoch has said that she was a 'tattle-tale' in school, revealing that she got a fellow pupil expelled after she caught him cheating in an exam. During an interview with Amol Rajan in his Interviews... series released on Thursday (7 August), the Conservative leader said that when she was '14 or 15' she stood up in the middle of a test and called out a boy who was breaking the rules. 'I've always hated cheating. I've done all the work and then there's some people who are copying notes and why should they get away with it?,' she said. She shared that she received no praise for 'snitching' on her fellow pupil, with one student telling her: 'You don't belong here.' Rajan quipped 'no wonder you were so unpopular back in school'.
Reuters
29 minutes ago
- Reuters
Focus: Trump, pharma industry discuss boosting medicine spending abroad to cut US prices, sources say
NEW YORK, Aug 7 (Reuters) - The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in order to cut drug costs in the United States, according to a White House official and three pharmaceutical industry sources. U.S. officials told drug companies it would support their international negotiations with governments if they adopt "most favored nation" pricing under which U.S. drug costs match the lower rates offered to other wealthy countries, the White House official said. The U.S. is currently negotiating bilateral trade deals and setting tariff rates on the sector. The Trump administration has asked some companies for ideas on raising prices abroad, two of the sources said, describing multiple meetings over several months aimed at lowering U.S. prices without triggering cuts to research and development spending drugmakers insist would result. The White House official called the effort collaborative, saying both sides were seeking advice from each other. The U.S. pays more for prescription drugs than any other country, often nearly three times as much as other developed nations. President Donald Trump has repeatedly said he wants to narrow this gap to stop Americans from being "ripped off." The previously unreported discussions reflect the challenges Trump faces to achieve that goal, and are the backdrop to the letters he sent last week to CEOs of 17 major drugmakers, urging them to cut U.S. prices to match those paid overseas. Unlike in the U.S., where market forces determine drug prices, European governments typically negotiate directly with companies to set prices for their national healthcare systems. Anna Kaltenboeck, a health economist at Verdant Research, said European nations have leverage to drive pricing and are sometimes willing to walk away from purchasing medicines they deem too expensive. Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's main lobby group - has always argued that cutting U.S. prices would stifle innovation by lowering R&D spending. PhRMA declined to comment on the private meetings. Kaltenboeck said past studies had shown that drugmakers made enough money in the U.S. to more than fund their entire global R&D spends. "Prices can come down in the United States without being increased in other countries, and we can still get innovation," she said. Despite the Trump administration's tariff threats and pressure to move more manufacturing to the U.S., the push to raise European drug prices is its top priority in discussions with industry, according to a senior executive at a European drugmaker, who spoke on condition of anonymity about the confidential meetings. "This is the key conversation right now with PhRMA and every company getting that message from Pennsylvania Avenue to a point that we are already executing on it," the executive said, referring to the White House address. The company had already met with European governments on the issue, the executive added. An E.U. Commission spokesperson said it is in regular contact with the pharma industry and pointed to an agreement with the U.S. that should it impose tariffs on pharmaceuticals, they would be capped at 15%. When asked how the administration would support international drug price negotiations, the White House official referred Reuters to Trump's most favored nation executive order from May. That order directed trade officials to pursue trade and legal action against countries keeping drug prices below fair market value. In last week's letters, Trump complained that since the May executive order, most industry proposals had simply shifted blame for high prices or requested policy changes that would result in billions in industry handouts. A second source, a pharmaceutical executive who was not authorized to speak on the matter, said the Trump administration has been continually meeting with representatives of his company and had discussed strategies for raising drug prices internationally. "There's a big push from the administration to drive up prices outside the U.S.," the executive said. The executive said the Trump administration had been looking at using trade talks with the UK and EU as leverage, and considered pressuring countries to spend a higher percentage of GDP on new medicines or offering tariff breaks in exchange for higher drug spending. It was understood that the UK deal specifically aims to get the country to ramp up investment in branded medicines over time, the executive said. A spokesperson for the UK government said it would continue to work closely with the U.S. and its own pharmaceutical industry to understand the possible impact of any changes to drug pricing, without commenting on the trade talks. In April, over 30 industry CEOs including those from AstraZeneca (AZN.L), opens new tab, Bayer ( opens new tab and Novo Nordisk ( opens new tab signed a letter to European Union President Ursula von der Leyen saying Europe needed to rethink its pricing policies. "It's going to be very difficult for a country that already has the ability to control what it spends to go in the other direction," Kaltenboeck said, "and it doesn't make much sense for them politically."
